Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;72(1):91-101.
doi: 10.1111/jgs.18665. Epub 2023 Nov 7.

Baclofen and the risk of fall and fracture in older adults: A real-world cohort study

Affiliations

Baclofen and the risk of fall and fracture in older adults: A real-world cohort study

Y Joseph Hwang et al. J Am Geriatr Soc. 2024 Jan.

Abstract

Background: The growth of oral muscle relaxant prescriptions among older adults in the United States is concerning due to the drugs' adverse sedative effects. Baclofen is a gamma-aminobutyric acid agonist muscle relaxant that is associated with encephalopathy. We characterized the risk of fall and fracture associated with oral baclofen against other muscle relaxants (tizanidine or cyclobenzaprine) in older adults.

Methods: We designed a new-user, active-comparator study using tertiary health system data from Geisinger Health, Pennsylvania (January 2005 through December 2018). Older adults (aged ≥65 years) newly treated with baclofen, tizanidine, or cyclobenzaprine were included. Propensity score-based inverse probability of treatment weighting (IPTW) was used to balance the treatment groups on 58 baseline characteristics. Fine-Gray competing risk regression was used to estimate the risk of fall and fracture.

Results: The study cohort comprised of 2205 new baclofen users, 1103 new tizanidine users, and 9708 new cyclobenzaprine users. During a median follow-up of 100 days, baclofen was associated with a higher risk of fall compared to tizanidine (IPTW incidence rate, 108.4 vs. 61.9 per 1000 person-years; subdistribution hazard ratio [SHR], 1.68 [95% CI, 1.20-2.36]). The risk of fall associated with baclofen was comparable to cyclobenzaprine (SHR, 1.17 [95% CI, 0.93-1.47]) with a median follow-up of 106 days. The risk of fracture was similar among patients treated with baclofen versus tizanidine (SHR, 0.85 [95% CI, 0.63-1.14]) or cyclobenzaprine (SHR, 0.85 [95% CI, 0.67-1.07]).

Conclusions: The risk of fall associated with baclofen was greater than tizanidine, but not compared to cyclobenzaprine in older adults. The risk of fracture was comparable among the older users of baclofen, tizanidine, and cyclobenzaprine. Our findings may inform risk-benefit considerations in the increasingly common clinical encounters where oral muscle relaxants are prescribed.

Keywords: baclofen; fall; fracture; muscle relaxant.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Authors have no relevant disclosures.

Similar articles

Cited by

References

    1. Soprano SE, Hennessy S, Bilker WB, Leonard CE. Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016. JAMA Netw Open 2020;3(6):e207664. - PMC - PubMed
    1. ClinCalc LLC. The Top 200 Drugs of 2020 [Internet]. 2021. [cited 2023 Jun 28];Available from: https://clincalc.com/DrugStats/
    1. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low-back pain. Cochrane Database Syst Rev 2003;2003(2):CD004252. - PMC - PubMed
    1. Romito JW, Turner ER, Rosener JA, et al. Baclofen therapeutics, toxicity, and withdrawal: A narrative review. SAGE Open Medicine 2021;9:205031212110221. - PMC - PubMed
    1. U.S. Food and Drug Administration. OZOBAX (baclofen) oral solution [Internet]. 2019. [cited 2022 Jan 21];Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208193s000lbl.pdf

Publication types

LinkOut - more resources